TomEnterprise Public Capital AB

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 65% 68% 82%
Transactions
10 80% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -24%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
TomEnterprise Public Capital AB's trades of Bactiguard Holding AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
26.35
Quantity 26,036
Value SEK4,698,397
Transaction date
Sale
Price
219.07
Quantity 17,105
Value SEK559,236
Transaction date
Purchase
Price
398.53
Quantity 50,855
Value SEK2,831,429
SE SynAct Pharma AB (SYNACT)
Transaction date
Purchase
Price
6.80
Quantity 1,118,210
Value SEK7,603,828
SE SynAct Pharma AB (SYNACT)
Transaction date
Sale
Price
6.80
Quantity 1,118,210
Value SEK7,603,828
Transaction date
Purchase
Price
66.35
Quantity 300,000
Value SEK19,905,000
Transaction date
Purchase
Price
105.00
Quantity 339,876
Value SEK35,686,980
Transaction date
Purchase
Price
105.00
Quantity 225,000
Value SEK23,625,000
Transaction date
Purchase
Price
105.00
Quantity 43,264
Value SEK4,542,720
Transaction date
Purchase
Price
105.00
Quantity 150,000
Value SEK15,750,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-14 2024-05-13
B Purchase
26,036
26.35
SEK4,698,397 		26,036 26.35 SEK4,698,397
2024-05-14 2024-05-13
S Sale
17,105
219.07
SEK559,236 		17,105 219.07 SEK559,236
2024-03-22 2024-03-21
B Purchase
50,855
398.53
SEK2,831,429 		50,855 398.53 SEK2,831,429
2024-03-06 2024-03-05
SE SynAct Pharma AB (SYNACT)
B Purchase
1,118,210
6.80
SEK7,603,828 		1,118,210 6.80 SEK7,603,828
2024-03-06 2024-03-05
SE SynAct Pharma AB (SYNACT)
S Sale
1,118,210
6.80
SEK7,603,828 		1,118,210 6.80 SEK7,603,828
2023-07-25 2023-07-21
B Purchase
300,000
66.35
SEK19,905,000 		300,000 66.35 SEK19,905,000
2022-11-09 2022-11-07
B Purchase
339,876
105.00
SEK35,686,980 		339,876 105.00 SEK35,686,980
2022-11-09 2022-11-07
B Purchase
225,000
105.00
SEK23,625,000 		225,000 105.00 SEK23,625,000
2022-11-09 2022-11-07
B Purchase
43,264
105.00
SEK4,542,720 		43,264 105.00 SEK4,542,720
2022-11-09 2022-11-04
B Purchase
150,000
105.00
SEK15,750,000 		150,000 105.00 SEK15,750,000